🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

6 Tablet(s) Serving Size
30 Servings
Other Combinations Product Type
33% Evidence Coverage

Supplement Facts — Evidence Check

30 mg (150% DV)
✅ 2.1× RDA — within safe limits 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 30mg UL 35mg
80 mg (2% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 80mg
Sodium
40 mg (2% DV)
Potassium
40 mg (1% DV)
N.O. Vasodilation Amplifier
2060 mg
Anabolic Muscle Primer
801 mg
📊 Market median: 5.0mg (298 products) 📚 701 studies (Tier A: 5, B: 123)
This product: 1250mg
Muscle Buffering System
700.05 mg
Thermo Energy Matrix
598.34 mg

Other Ingredients

Cellulose Dicalcium Phosphate

Label Claims — Verification

All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

DIRECTIONS: As a dietary supplement, take six tablets 30 minutes before exercise.

⚠️ Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

Do not exceed six tablets daily.

WARNING: Use only as directed. Do not exceed recommended daily intake. Consult your physician prior to using this product if you are pregnant, nursing, under 18 years of age, taking medication, or have a medical condition. Discontinue use two weeks prior to surgery.

🧪 Formulation Notes

No Artificial Flavors, No Wheat, No Gluten, No Dairy, Yeast Free.

Each serving supplies 200 mg of caffeine.

Additional Information

Store in a cool, dry place.

POTENT PRE-TRAINING PERFORMANCE AMPLIFIER

+ ENERGIZES MUSCLE SYSTEMS AND BOOSTS MUSCLE ANABOLISM

+ HARDCORE MUSCLE BUFFERING COMPOUNDS COMBAT FREE RADICALS DURING EXPLOSIVE WORKOUTS

+ INTENSE PUMPS WITH ADVANCED NITRIC OXIDE BOOSTERS

+ THERMO ENERGY MATRIX FUELS RAZOR SHARP FOCUS AND TRAINING THAT DRIVES EXTREME VASCULARITY

Code 826410 CNG

Conforms to USP <2091> for weight. Meets USP <2040> disintegration.

Lot No./Best By:

STACK WITH: GNC BEYOND RAW(R) Re-Power and Re-Grow.

Product Details

UPC / SKU 0 48107 10908 0
DSLD Entry Date 2013-02-25
Product Type Other Combinations
Form Tablet or Pill
DSLD ID 14168
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →